Ignite Creation Date:
2024-05-05 @ 5:18 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00425997
Status:
COMPLETED
Last Update Posted:
2011-06-08
First Post:
2007-01-23
Brief Title:
Efficacy of ValsartanHydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A 10-week MulticenterForced-titration Study Using 24-hr ABPM to Evaluate the Efficacy of ValsartanHydrochlorothiazide HCTZ Treatment Regimen vs Conventional Treatment Regimen With Amlodipine and Hydrochlorothiazide HCTZ in Patients With Stage 2 Hypertension
Status:
COMPLETED
Status Verified Date:
2011-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the efficacy of valsartanhydrochlorothiazide versus amlodipine and hydrochlorothiazide in patients with Stage 2 hypertension using 24-hr ambulatory blood pressure monitoring ABPM
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None